Publication related to RSI or an RSI staff member

Radon and nonrespiratory mortality in the American Cancer Society cohort.

Radon is a known cause of human lung cancer. Previously, the authors observed a significant positive association between mean county-level residential radon concentrations and lung cancer mortality in the Cancer Prevention Study II (CPS-II), a large prospective study of nearly 1.2 million participants recruited in 1982 by the American Cancer Society. There was also a significant positive association with mortality from chronic obstructive pulmonary disease. Because it is unclear whether radon is associated with mortality from other malignant or nonmalignant disease, the authors examined the association between radon and nonrespiratory mortality in the CPS-II. Mean county-level residential radon concentrations (mean = 53.5 (standard deviation: 38.0) Bq/m(3)) were linked to participants by their zip code at enrollment. Cox proportional hazards regression models were used to estimate adjusted hazard ratios and 95% confidence intervals for all-cause (excluding lung cancer and respiratory mortality) and cause-specific mortality associated with radon concentrations. A total of 811,961 participants in 2,754 counties were analyzed, including 265,477 deaths through 2006. There were no clear associations between radon and nonrespiratory mortality in the CPS-II. These findings suggest that residential radon is not associated with any other mortality beyond lung cancer or chronic obstructive pulmonary disease.

Authors

  • Turner, Michelle C, Turner MC, Faculty of Graduate and Postdoctoral Studies, University of Ottawa, Ontario, Canada. mturner@uottawa.ca

  • Krewski, Daniel, Krewski D,

  • Chen, Yue, Chen Y,

  • Pope, C Arden 3rd, Pope CA 3rd,

  • Gapstur, Susan M, Gapstur SM,

  • Thun, Michael J, Thun MJ,

YEAR OF PUBLICATION: 2012
SOURCE: Am J Epidemiol. 2012 Nov 1;176(9):808-14. doi: 10.1093/aje/kws198. Epub 2012 Oct 7.
JOURNAL TITLE ABBREVIATION: Am J Epidemiol
JOURNAL TITLE: American journal of epidemiology
ISSN: 1476-6256 (Electronic) 0002-9262 (Linking)
VOLUME: 176
ISSUE: 9
PAGES: 808-14
PLACE OF PUBLICATION: United States
ABSTRACT:
Radon is a known cause of human lung cancer. Previously, the authors observed a significant positive association between mean county-level residential radon concentrations and lung cancer mortality in the Cancer Prevention Study II (CPS-II), a large prospective study of nearly 1.2 million participants recruited in 1982 by the American Cancer Society. There was also a significant positive association with mortality from chronic obstructive pulmonary disease. Because it is unclear whether radon is associated with mortality from other malignant or nonmalignant disease, the authors examined the association between radon and nonrespiratory mortality in the CPS-II. Mean county-level residential radon concentrations (mean = 53.5 (standard deviation: 38.0) Bq/m(3)) were linked to participants by their zip code at enrollment. Cox proportional hazards regression models were used to estimate adjusted hazard ratios and 95% confidence intervals for all-cause (excluding lung cancer and respiratory mortality) and cause-specific mortality associated with radon concentrations. A total of 811,961 participants in 2,754 counties were analyzed, including 265,477 deaths through 2006. There were no clear associations between radon and nonrespiratory mortality in the CPS-II. These findings suggest that residential radon is not associated with any other mortality beyond lung cancer or chronic obstructive pulmonary disease.
LANGUAGE: eng
DATE OF PUBLICATION: 2012 Nov 1
DATE OF ELECTRONIC PUBLICATION: 20121007
DATE COMPLETED: 20130114
DATE REVISED: 20131121
MESH DATE: 2013/01/15 06:00
EDAT: 2012/10/10 06:00
STATUS: MEDLINE
PUBLICATION STATUS: ppublish
LOCATION IDENTIFIER: 10.1093/aje/kws198 [doi]
OWNER: NLM

Related RSI Experts

Daniel Krewski

Chief Risk Scientist

Dr. Daniel Krewski is Chief Risk Scientist and co-founder of Risk Sciences International (RSI), a firm established in 2006 to bring evidence-based, multidisciplinary expertise to the challenge of understanding, managing, and communicating risk. As RSI’s inaugural CEO and long-time scientific...
Read More about Daniel Krewski